Suppr超能文献

家庭生物反馈与物理疗法治疗压力性尿失禁的随机试验。

Home Biofeedback Versus Physical Therapy for Stress Urinary Incontinence: A Randomized Trial.

机构信息

From the Division of Urogynecology, Department of Obstetrics and Gynecology, University of New Mexico Health Science Center, Albuquerque, NM.

Division of Urogynecology, Department of Obstetrics and Gynecology, Oregon Health & Science University School of Medicine, Portland, OR.

出版信息

Female Pelvic Med Reconstr Surg. 2021 Oct 1;27(10):587-594. doi: 10.1097/SPV.0000000000000993.

Abstract

OBJECTIVE

The aim of the study was to assess whether home biofeedback is noninferior to supervised pelvic floor physical therapy (PFPT) for the treatment of stress urinary incontinence (SUI) in women.

METHODS

The study used a randomized controlled noninferiority trial to compare a home biofeedback device with PFPT. Women older than 18 years with SUI and no history of a prior incontinence surgery or PFPT were eligible. Forty-two participants were required to determine noninferiority for the primary outcome, improvement in quality of life as measured by the International Consultation on Incontinence Questionnaire Short Form. The noninferiority margin was 4 points. Secondary outcomes included sexual function, overactive bladder symptoms, and patient impression of improvement.

RESULTS

From June 2018 to October 2019, 54 women with SUI were recruited (27 biofeedback, 27 PFPT) and 43 (21 biofeedback, 22 PFPT) completed follow-up. The groups had comparable baseline characteristics. For the primary outcome of change in mean International Consultation on Incontinence Questionnaire-Short Form scores (where lower scores indicate less incontinence), home biofeedback was found to be noninferior to PFPT with a mean decrease from baseline of -3.95 (95% confidence interval [CI] = -2.21 to -5.70) in the home biofeedback group versus -4.73 (95% CI = -3.21 to -6.25) and -3.95 (95% CI = -2.21 to -5.70) in the PFPT group (P = 0.009). The PFPT group showed more improvement in overactive bladder symptoms, but not in incontinence severity without difference in sexual function.

CONCLUSIONS

Home biofeedback was noninferior to PFPT for the primary treatment of SUI in women at 3 months. These results support the use of personal biofeedback devices for the treatment of SUI.Clinical Trial Registration: ClinicalTrials.gov, http://www.clinicaltrials.gov, NCT03443687.

摘要

目的

本研究旨在评估家庭生物反馈是否不劣于监督下的盆底物理疗法(PFPT)治疗女性压力性尿失禁(SUI)。

方法

本研究采用随机对照非劣效性试验比较家庭生物反馈设备与 PFPT。年龄大于 18 岁、患有 SUI 且无既往失禁手术或 PFPT 史的女性符合条件。需要 42 名参与者确定主要结局(生活质量改善,用国际尿失禁咨询问卷简表测量)的非劣效性。非劣效性边界为 4 分。次要结局包括性功能、膀胱过度活动症症状和患者对改善的印象。

结果

2018 年 6 月至 2019 年 10 月,共招募 54 名 SUI 女性(家庭生物反馈组 27 名,PFPT 组 27 名),其中 43 名(家庭生物反馈组 21 名,PFPT 组 22 名)完成了随访。两组基线特征具有可比性。对于国际尿失禁咨询问卷-短表评分变化的主要结局(分数越低表示失禁越少),家庭生物反馈被发现不劣于 PFPT,家庭生物反馈组从基线下降的平均值为-3.95(95%置信区间[CI] = -2.21 至 -5.70),而 PFPT 组为-4.73(95%CI = -3.21 至 -6.25)和-3.95(95%CI = -2.21 至 -5.70)(P = 0.009)。PFPT 组在膀胱过度活动症症状方面的改善更为明显,但在失禁严重程度方面无差异,性功能也无差异。

结论

家庭生物反馈在 3 个月时治疗女性 SUI 的主要治疗不劣于 PFPT。这些结果支持使用个人生物反馈设备治疗 SUI。

临床试验注册

ClinicalTrials.gov,http://www.clinicaltrials.gov,NCT03443687。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验